These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Swank LA; Chejfec G; Nemchausky BA Arch Intern Med; 1978 Jun; 138(6):997-8. PubMed ID: 646570 [TBL] [Abstract][Full Text] [Related]
3. [Liver damage due to phenylbutazone and chlorpropamide]. Grottum KA Tidsskr Nor Laegeforen; 1966 Aug; 86(16):1096-8. PubMed ID: 5919203 [No Abstract] [Full Text] [Related]
4. Fatal hepatitis due to phenylbutazone in a child. Dhatt PS; Singh H; Gupta HL; Arya RK Indian J Pediatr; 1973 Aug; 40(307):293-4. PubMed ID: 4769816 [No Abstract] [Full Text] [Related]
5. Phenylbutazone and hepatitis. Fowler PD; Woolf D; Alexander S Rheumatol Rehabil; 1975 May; 14(2):71-5. PubMed ID: 1145012 [TBL] [Abstract][Full Text] [Related]
7. Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases. Ishak KG; Kirchner JP; Dhar JK Am J Dig Dis; 1977 Jul; 22(7):611-7. PubMed ID: 879127 [TBL] [Abstract][Full Text] [Related]
8. Morphological aspects of hepatitis induced by phenylbutazone derivatives. Observations on two cases. Coltorti M; Cuccurullo L; Del Vecchio Blanco C Acta Hepatosplenol; 1971; 18(3):206-15. PubMed ID: 5089187 [No Abstract] [Full Text] [Related]
9. [Improved compatibility of phenylbutazone drugs. A new antirheumatic agent in sugar-coated tablets, suppositories, ampoules]. Dürrigl T; Vitaus M Munch Med Wochenschr; 1969 Mar; 111(10):564-8. PubMed ID: 4239143 [No Abstract] [Full Text] [Related]
10. [Multiple manifestations of intolerance of a combination of anti-inflammatory drugs. Role of phenylbutazone]. Tolot F; Prost G; Guignot B; Pelletier M Sem Hop; 1975 Dec; 51(48):2555-60. PubMed ID: 175502 [No Abstract] [Full Text] [Related]
11. [Acute interstitial nephritis with oliguric renal failure following phenylbutazone medication]. Kuhlmann U; Fontana A; Briner J; Steinemann U; Siegenthaler W Schweiz Med Wochenschr; 1978 Apr; 108(13):494-9. PubMed ID: 147510 [TBL] [Abstract][Full Text] [Related]
12. [Non-steroidal antirheumatic therapy and the liver]. Frank O Acta Med Austriaca; 1975; 2(4):145-8. PubMed ID: 1224930 [TBL] [Abstract][Full Text] [Related]
15. Phenylbutazone in treatment of acute lumbago-sciatica. Grevsten S; Johansson H Z Rheumatol; 1975; 34(11-12):444-7. PubMed ID: 128937 [TBL] [Abstract][Full Text] [Related]
17. [Drug-induced lesion of the liver]. Ivlev AS; Polunina TE Voen Med Zh; 1987 Jun; (6):60-1. PubMed ID: 3660719 [No Abstract] [Full Text] [Related]
18. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Benjamin SB; Ishak KG; Zimmerman HJ; Grushka A Hepatology; 1981; 1(3):255-63. PubMed ID: 7286906 [TBL] [Abstract][Full Text] [Related]
19. Lung changes associated with phenylbutazone treatment. Thurston JG; Marks P; Trapnell D Br Med J; 1976 Dec; 2(6049):1422-3. PubMed ID: 1009358 [No Abstract] [Full Text] [Related]
20. The effect of phenylbutazone on patients with acute lumbago-sciatica. A double blind trial. Weber H; Aasand G J Oslo City Hosp; 1980 May; 30(5):69-72. PubMed ID: 6446598 [No Abstract] [Full Text] [Related] [Next] [New Search]